Trial Profile
Phase II trial of intravenous palifosfamide in combination with etoposide and carboplatin in patients with small cell lung cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2022
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Etoposide (Primary) ; Palifosfamide (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alaunos Therapeutics
- 17 Nov 2011 New trial record